Shet Manjunath S, Fisher Charles W, Tremblay Yves, Belanger Alain, Conley Alan J, Mason J Ian, Estabrook Ronald W
Purdue Pharma LP, Department of Pharmocokinetics and Drug Metabolism, Stamford, Connecticut, USA.
Drug Metab Rev. 2007;39(2-3):289-307. doi: 10.1080/03602530701468391.
The cDNAs for cytochrome P450c17 (P450c17) of three species, pig, guinea pig, and cow, representing three families of mammals (suidae, procaviidae, and bovidae, respectively) were each engineered into an expression plasmid (pCWori+). The P450c17 domain of the coding sequence was connected to a truncated form of rat NADPH-P450 reductase by a linker sequence encoding two amino acids (SerThr). These fusion proteins were expressed in E. coli and purified for use in enzymatic assays to determine similarities and differences in 17 alpha-hydroxylase and lyase activities. The fusion proteins were found to catalyze both the 17 alpha-hydroxylation of progesterone (P4) and pregnenolone (P5) to 17 alpha-hydroxylated P4 and P5 (17 alpha-OH P4 and 17 alpha-OH P5) followed by the C17,20-lyase reaction for the conversion of these C(21)-17 alpha-hydroxylated steroids to C(19)-steroids (the C17,20-lyase reaction). These in vitro studies show that (a) porcine P450c17 possesses cytochrome b(5) (b(5))-stimulated C17,20-lyase activity that converts 17 alpha OH-P4 to androstenedione (AD) but also converts 17 alpha-OHP5 to dehydroepiandrosterone (DHEA); (b) guinea pig P450c17 possesses a b(5)-stimulated C17,20-lyase activity that converts 17 alpha-OH P4 to AD but does not convert 17 alpha-OH P5 to DHEA., and (c) bovine P450c17 possesses a b(5)-stimulated C17,20-lyase activity that converts 17 alpha-OH P5 to DHEA but does not convert 17 alpha-OH P4 to AD. Thus, the P450c17 of each species differs in its ability to catalyze in vitro the conversion of C(21)-steroids to C(19)-steroids. In addition, each P450c17 is capable of catalyzing additional hydroxylation reactions leading to low levels of 2 alpha-, 6 beta-, 16- and 21-hydroxy-metabolites. Porcine P450c17 also catalyzes the b(5)-dependent synthesis of andien-beta (androsta-5,16-dien-3beta-ol) from P5. When the amino acid sequences of the three P450c17s were aligned there was an approximate 50% variation in the alignment identity (227 differences in the sequences of 509 amino acids). Alignment did not permit the assignment of specific amino acids or domains to the observed differences in enzymatic activities.
猪、豚鼠和牛这三个物种的细胞色素P450c17(P450c17)的互补DNA(cDNA),分别代表三个哺乳动物家族(猪科、豚鼠科和牛科),各自被构建到一个表达质粒(pCWori+)中。编码序列的P450c17结构域通过编码两个氨基酸(丝氨酸-苏氨酸)的接头序列与大鼠NADPH-P450还原酶的截短形式相连。这些融合蛋白在大肠杆菌中表达并纯化,用于酶活性测定,以确定17α-羟化酶和裂解酶活性的异同。发现这些融合蛋白既能催化孕酮(P4)和孕烯醇酮(P5)的17α-羟化反应生成17α-羟化的P4和P5(17α-OH P4和17α-OH P5),随后进行C17,20-裂解酶反应,将这些C(21)-17α-羟化类固醇转化为C(19)-类固醇(C17,20-裂解酶反应)。这些体外研究表明:(a)猪的P450c17具有细胞色素b(5)(b(5))刺激的C17,20-裂解酶活性,可将17α-OH-P4转化为雄烯二酮(AD),也可将17α-OHP5转化为脱氢表雄酮(DHEA);(b)豚鼠的P450c17具有b(5)刺激的C17,20-裂解酶活性,可将17α-OH P4转化为AD,但不能将17α-OH P5转化为DHEA;(c)牛的P450c17具有b(5)刺激的C17,20-裂解酶活性,可将来17α-OH P5转化为DHEA,但不能将17α-OH P4转化为AD。因此,每个物种的P450c17在体外催化C(21)-类固醇转化为C(19)-类固醇的能力上存在差异。此外,每个P450c17都能够催化额外的羟化反应,生成低水平的2α-、6β-、16-和21-羟基代谢产物。猪的P450c17还能催化由P5生成andien-β(雄甾-5,16-二烯-3β-醇)的b(5)依赖性合成反应。当对这三种P450c17的氨基酸序列进行比对时,比对一致性存在约50%的差异(在509个氨基酸的序列中有227个差异)。序列比对无法将特定的氨基酸或结构域与观察到的酶活性差异对应起来。